Pacira Pharmaceuticals

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 7
Rounds per year 0.30
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.30
Exits 1
Key employees 1

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Health Care
  • Life Science
Summary

Pacira Pharmaceuticals is the famous Corporate Investor, which was founded in 1989. The main department of described Corporate Investor is located in the San Diego. The venture was found in North America in United States.

The increased amount of exits for fund were in 2019. The important activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.

The typical case for the fund is to invest in rounds with 4 participants. The meaningful sponsors for the fund in investment in the same round are Signet Healthcare Partners, Quaker Partners, OrbiMed. In the next rounds fund is usually obtained by ProMedica Health System, Checkmate Capital.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Life Science. Among the various public portfolio startups of the fund, we may underline TELA Bio For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pacira Pharmaceuticals:
Typical Co-investors
Pacira Pharmaceuticals is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pacira Pharmaceuticals:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aeternity Liechtenstein, Oberland, Vaduz
APY Ventures Istanbul, Istanbul, Turkey
Avid Ventures New York, New York, United States
Black Capital -
Eastic Beijing, Beijing, China
Formica Ventures -
GX Software Gelderland, Netherlands, Nijmegen
Kunshan Hi-tech Venture Capital China, Jiangsu, Suzhou
Macromill Chiba Prefecture, Japan, Tateyama
MidMark Capital Morristown, New Jersey, United States
Movistar Community of Madrid, Madrid, Spain
OMERS Private Equity Canada, Ontario, Toronto
Theorem Ventures California, San Francisco, United States
Towerview Ventures -
Unity Ventures Budapest, Hungary
Zhenru Investment Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CarthroniX

Biotechnology
Medical
Pharmaceutical
$2M11 Apr 2022 Lancaster, California, United States

Spine BioPharma

Biotechnology
Medical
Pharmaceutical
$13M28 Mar 2022 New York, New York, United States

Genascence

Biotechnology
$10M07 Jan 2022 -

CODA Biotherapeutics

Biotechnology
Therapeutics
$28M02 Dec 2021 South San Francisco, California, United States

Spine BioPharma

Biotechnology
Medical
Pharmaceutical
$3M20 Apr 2021 New York, New York, United States

GeneQuine Biotherapeutics GmbH

Biopharma
Biotechnology
Developer Tools
Health Care
$6M15 Feb 2021 Germany, Baden-Württemberg, Germany

AVALON.AI

Health Care
Information Technology
Medical
Software
$1M28 Aug 2020 New York, United States

TELA Bio

Biotechnology
Life Science
Pharmaceutical
$25M30 Oct 2017 Pennsylvania, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pacira Pharmaceuticals?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: